Hype around worm study on potential Alzheimer's treatment is derided

A group of scientists from the University of Cambridge, Lund University and the University of Groningen concluded that the lymphoma drug bexarotene may interrupt the first step in the process that leads to Alzheimer's. The conclusion was reached after studying the drug on worm models for the disease. And the resulting headlines in U.K. newspapers about a potential cure for Alzheimer's led to considerable hooting on Twitter, where it was called out as another example of hyping preclinical studies. Release

Sponsored By Paraza Pharma

Choosing the Right Pre-Clinical Collaborative Research Organization (CRO)

Learn about the key factors that are essential to creating a collaborative and productive working relationship to advance pre-clinical drug discovery programs.